×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of ...
Yahoo Finance
Patient Enrollment Has Accelerated with Now 10 Patients Enrolled in Phase 2 Trial 6 out of 6 Patients Who Completed the 12-Week Treatment...
24 hours ago
TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
TFF Pharmaceuticals (TFFP) delivered earnings and revenue surprises of -9.09% and 35.33%, respectively, for the quarter ended March 2024.
1 day ago
TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
Yahoo Finance
Growing Body of Clinical Data from Ongoing Phase 2 Trial Suggests that Tacrolimus Inhalation Powder (TFF TAC) Could Represent an Important...
1 day ago
TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Tops Revenue Estimates
MSN
TFF Pharmaceuticals, Inc. (TFFP) came out with a quarterly loss of $2.40 per share versus the Zacks Consensus Estimate of a loss of $2.20.
1 day ago
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering
GlobeNewswire
FORT WORTH, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”),...
2 weeks ago
TFF Pharmaceuticals reports progress in Phase 2 lung trial
Investing.com South Africa
FORT WORTH, Texas - TFF Pharmaceuticals, Inc. ( NASDAQ :TFFP), a clinical-stage biopharmaceutical company, announced significant...
14 hours ago
Aptar Pharma TFF Pharmaceuticals Collaboration
Aptar
To develop intranasal delivery of dry powder vaccines and therapeutics.
6 months ago
TFF Pharmaceuticals Full Year 2023 Earnings: Misses Expectations
Simply Wall Street
TFF Pharmaceuticals ( NASDAQ:TFFP ) Full Year 2023 Results Key Financial Results Net loss: US$21.2m (loss narrowed by...
1 month ago
TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering
GlobeNewswire
FORT WORTH, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”),...
2 weeks ago
Loss-Making TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Expected To Breakeven In The Medium-Term
Yahoo Movies Canada
We feel now is a pretty good time to analyse TFF Pharmaceuticals, Inc.'s ( NASDAQ:TFFP ) business as it appears the...
2 days ago